SYSTEMATIC REVIEW
Year : 2023 | Volume
: 16 | Issue : 2 | Page : 51--57
Application of next-generation sequencing in thalassemia screening: A systematic review and meta-analysis
Xingyi Fang1, Yi Gong2, Yanlin Ma1, Yuanhua Huang1
1 Hainan Provincial Key Laboratory for Human Reproductive Medicine and Genetic Research, Reproductive Medical Center, International Technology Cooperation Base "China-Myanmar Joint Research Center for Prevention and Treatment of Regional Major Disease" by the Ministry of Science and Technology of China, the First Affiliated Hospital of Hainan Medical University, Hainan Medical University; Key Laboratory of Tropical Translational Medicine of Ministry of Education, Hainan Medical University; Hainan Provincial Clinical Research Center for Thalassemia, the First Affiliated Hospital of Hainan Medical University, Hainan Medical University, Haikou 570102, China
2 Key Laboratory of Tropical Translational Medicine of Ministry of Education, Hainan Medical University; Hainan Provincial Clinical Research Center for Thalassemia, the First Affiliated Hospital of Hainan Medical University, Hainan Medical University; Department of Obstetrics and Gynecology, Southern Medical University Nanfang Hospital, Guangzhou 510515, China
Correspondence Address:
Yuanhua Huang
Hainan Provincial Key Laboratory for Human Reproductive Medicine and Genetic Research, Reproductive Medical Center, International Technology Cooperation Base "China-Myanmar Joint Research Center for Prevention and Treatment of Regional Major Disease" by the Ministry of Science and Technology of China, the First Affiliated Hospital of Hainan Medical University, Hainan Medical University; Key Laboratory of Tropical Translational Medicine of Ministry of Education, Hainan Medical University; Hainan Provincial Clinical Research Center for Thalassemia, the First Affiliated Hospital of Hainan Medical University, Hainan Medical University, Haikou 570102
China
Objective: To evaluate the value of next-generation sequencing (NGS) in the prevention and management of thalassemia.
Methods: A systematic search was performed in eight databases including China Biomedical Literature Database, Chinese National Knowledge Infrastructure, Chinese Scientific Journals Database, Wanfang database, PubMed, EMBASE, Web of Science, and Cochrane Library from the inception to 1 June 2022. Stata 17.0 and Review Manager 5.4 were used for the meta-analysis.
Results: Nine studies containing 14794 participants were included in the meta-analysis. Compared with the routine genetic testing (including Gap-PCR and reverse dot blot), NGS had higher detection rates in screening thalassemia (RR 1.22, 95% CI 1.13-1.31, P<0.01), particularly for the α-thalassaemia mutation carriers (RR 1.24, 95% CI 1.07-1.44, P<0.01). However, no significant difference was found in the screening of β-thalassemia (RR 1.10, 95% CI 0.99-1.23, P>0.05).
Conclusions: Compared with routine genetic testing, NGS had a higher detection rate in general, particularly in the detection of α-thalassemia.
How to cite this article:
Fang X, Gong Y, Ma Y, Huang Y. Application of next-generation sequencing in thalassemia screening: A systematic review and meta-analysis.Asian Pac J Trop Med 2023;16:51-57
|
How to cite this URL:
Fang X, Gong Y, Ma Y, Huang Y. Application of next-generation sequencing in thalassemia screening: A systematic review and meta-analysis. Asian Pac J Trop Med [serial online] 2023 [cited 2023 Mar 20 ];16:51-57
Available from: https://www.apjtm.org/article.asp?issn=1995-7645;year=2023;volume=16;issue=2;spage=51;epage=57;aulast=Fang;type=0 |
|
